Gamma Plus V/ DE000A3CT6E6 /
NAV2024-04-19 | Chg.+0.0300 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
103.9600EUR | +0.03% | reinvestment | Alternative Investments Worldwide | HANSAINVEST ▶ |
GlobeNewswire
04-16
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
GlobeNewswire
04-16
Standard Uranium Reports on Recent Exploration Insights at the Sun Dog Project with Option Partner A...
GlobeNewswire
04-15
Neurona Therapeutics Presents Positive Clinical Update from NRTX-1001 Cell Therapy Trial in Adults w...
GlobeNewswire
04-13
American Shared Hospital Services Announces the Sudden Passing of CEO, Peter Gaccione
GlobeNewswire
04-11
Standard Uranium Intersects Anomalous Radioactivity, Prospective Structure and Alteration in Multipl...
GlobeNewswire
04-10
AFC Gamma, Inc. Schedules First Quarter 2024 Earnings Conference Call for May 9, 2024
GlobeNewswire
04-09
ALX Oncology Reports Encouraging Clinical Data of Evorpacept in Combination with Standard-of-Care in...
GlobeNewswire
04-09
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
GlobeNewswire
04-09
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Associati...
GlobeNewswire
04-08
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform T...
GlobeNewswire
04-05
23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association f...
GlobeNewswire
04-05
Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC
GlobeNewswire
04-04
FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a ...
GlobeNewswire
04-03
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Ann...
GlobeNewswire
04-02
Global Uranium Production to Increase as Prices Are Expected to Hit a 15 Year High
GlobeNewswire
04-01
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Fin...
GlobeNewswire
03-28
Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for...